Titration of basal insulin or immediate addition of rapid acting insulin in patients not at target using basal insulin supported oral antidiabetic treatment – A prospective observational study in 2202 patients-Reference-Cited by-同舟云学术

Titration of basal insulin or immediate addition of rapid acting insulin in patients not at target using basal insulin supported oral antidiabetic treatment – A prospective observational study in 2202 patients

Published:2017-01 Issue:1 Volume:11 Page:51-57
ISSN:1871-4021
Container-title:Diabetes & Metabolic Syndrome: Clinical Research & Reviews
language:en
Short-container-title:Diabetes & Metabolic Syndrome: Clinical Research & Reviews

Author:

Siegmund Thorsten,Pfohl Martin,Forst Thomas,Pscherer Stefan,Bramlage Peter,Foersch Johannes,Borck Anja,Seufert Jochen

Publisher

Elsevier BV

Subject

General Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference38 articles.

1. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group;Lancet,1998

2. 10-year follow-up of intensive glucose control in type 2 diabetes;Holman;N Engl J Med,2008

3. Long-term results of the Kumamoto study on optimal diabetes control in type 2 diabetic patients;Shichiri;Diabetes Care,2000

4. Cost-effectiveness of intensive insulin therapy for type 2 diabetes: a 10-year follow-up of the Kumamoto study;Wake;Diabetes Res Clin Pract,2000

5. American Diabetes Association Standards of medical care in diabetes–2015: summary of revisions;Diabetes Care,2015

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Injektionstherapie (GLP1-Rezeptor Agonisten und Insulin) bei Typ 2 Diabetes mellitus (Update 2023);Wiener klinische Wochenschrift;2023-01

2. Insulintherapie bei Typ 2 Diabetes mellitus (Update 2019);Wiener klinische Wochenschrift;2019-04-12

3. Use of glucagon-like peptide-1 receptor agonists among individuals on basal insulin requiring treatment intensification;Diabetic Medicine;2018-03-24